# CR161 Release Notes

## Summary

CR161 delivers a design-only strategy admission evidence contract. It makes missing mandatory evidence visible and fail-closed through `typed_unavailable`, without claiming that statistical or economic evidence has been computed.

## Delivered

- Seven evidence objects are explicitly modeled.
- `typed_unavailable` fail-closed claim-tier semantics are defined.
- CR151/CR154 integration remains through evidence refs and summaries.
- CR155 remains a blocked negative regression.
- CP4/CP5/CP6 are N/A for the approved design-only route.
- CP7 verification completed with `PASS_WITH_RISK`.
- CP7 fallback evidence is auditable, but independent meta-qa verification was not completed; closure carries a time-bounded CP8 waiver.

## Not Delivered

- FDR/PBO/DSR computation.
- Walk-forward fold-level OOS computation.
- Real TCA, market impact or capacity sizing implementation.
- Research-engine trial lineage instrumentation.
- Source/test/schema/checker implementation.

## Release Decision

`READY_WITH_RISK` for design closure only, including an explicit verifier-independence waiver.

This is not `RELEASED`, not independently QA-verified, not runtime-ready, and not paper/simulation/live/trading-ready.
